Kewalramani Reshma sold VRTX
February 10, 2025 · Form 4 insider transaction
Kewalramani Reshma sold 8,300 shares of Vertex Pharmaceuticals Incorporated at $467.98 per share, a transaction worth $3.88M. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
8,300
Price
$467.98
Total value
$3.88M
InsiderKewalramani Reshma
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 10, 2025
Filing dateFebruary 12, 2025
Shares owned after116,918
OwnershipDirect
10b5-1 planNo
AmendedNo